These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 12867511)

  • 1. Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment.
    Deplanque D; Gelé P; Pétrault O; Six I; Furman C; Bouly M; Nion S; Dupuis B; Leys D; Fruchart JC; Cecchelli R; Staels B; Duriez P; Bordet R
    J Neurosci; 2003 Jul; 23(15):6264-71. PubMed ID: 12867511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of single and combined PPAR-α and PPAR-γ activation on the neurological outcomes following cerebral ischemia reperfusion.
    Shehata AHF; Ahmed AF; Abdelrehim AB; Heeba GH
    Life Sci; 2020 Jul; 252():117679. PubMed ID: 32325134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
    J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
    Tureyen K; Kapadia R; Bowen KK; Satriotomo I; Liang J; Feinstein DL; Vemuganti R
    J Neurochem; 2007 Apr; 101(1):41-56. PubMed ID: 17394460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective Effects of Chronic Fenofibrate Treatment via Modulating the Immunoreactivity of Cleaved Caspase-3 in Stroke Induced by Transient Middle Cerebral Artery Occlusion Rat Model.
    Altintas O; Altintas MO; Aydin MS; Baran O; Antar V; Esrefoglu M; Asil T
    Turk Neurosurg; 2017; 27(4):522-529. PubMed ID: 27509457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic renal failure alters endothelial function in cerebral circulation in mice.
    Bugnicourt JM; Da Silveira C; Bengrine A; Godefroy O; Baumbach G; Sevestre H; Bode-Boeger SM; Kielstein JT; Massy ZA; Chillon JM
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1143-52. PubMed ID: 21705678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice.
    Laufs U; Gertz K; Dirnagl U; Böhm M; Nickenig G; Endres M
    Brain Res; 2002 Jun; 942(1-2):23-30. PubMed ID: 12031849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARα is involved in the multitargeted effects of a pretreatment with atorvastatin in experimental stroke.
    Ouk T; Potey C; Laprais M; Gautier S; Hanf R; Darteil R; Staels B; Duriez P; Bordet R
    Fundam Clin Pharmacol; 2014 Jun; 28(3):294-302. PubMed ID: 23701370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenofibrate improves cerebral blood flow after middle cerebral artery occlusion in mice.
    Guo Q; Wang G; Namura S
    J Cereb Blood Flow Metab; 2010 Jan; 30(1):70-8. PubMed ID: 19724288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the peroxisome proliferator-activated receptor alpha protects against myocardial ischaemic injury and improves endothelial vasodilatation.
    Tabernero A; Schoonjans K; Jesel L; Carpusca I; Auwerx J; Andriantsitohaina R
    BMC Pharmacol; 2002 Apr; 2():10. PubMed ID: 11940253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats.
    Diep QN; Benkirane K; Amiri F; Cohn JS; Endemann D; Schiffrin EL
    J Mol Cell Cardiol; 2004 Feb; 36(2):295-304. PubMed ID: 14871557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids.
    Limbourg FP; Huang Z; Plumier JC; Simoncini T; Fujioka M; Tuckermann J; Schütz G; Moskowitz MA; Liao JK
    J Clin Invest; 2002 Dec; 110(11):1729-38. PubMed ID: 12464678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the PPAR-α agonist fenofibrate on acute and short-term consequences of brain ischemia.
    Ouk T; Gautier S; Pétrault M; Montaigne D; Maréchal X; Masse I; Devedjian JC; Deplanque D; Bastide M; Nevière R; Duriez P; Staels B; Pasquier F; Leys D; Bordet R
    J Cereb Blood Flow Metab; 2014 Mar; 34(3):542-51. PubMed ID: 24398933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury.
    Chen XR; Besson VC; Palmier B; Garcia Y; Plotkine M; Marchand-Leroux C
    J Neurotrauma; 2007 Jul; 24(7):1119-31. PubMed ID: 17610352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury.
    Besson VC; Chen XR; Plotkine M; Marchand-Verrecchia C
    Neurosci Lett; 2005 Nov; 388(1):7-12. PubMed ID: 16087294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal of fenofibrate treatment partially abrogates preventive neuroprotection in stroke via loss of vascular protection.
    Ouk T; Laprais M; Bastide M; Mostafa K; Gautier S; Bordet R
    Vascul Pharmacol; 2009; 51(5-6):323-30. PubMed ID: 19732852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mindin is a critical mediator of ischemic brain injury in an experimental stroke model.
    Wang L; Lu Y; Zhang X; Zhang Y; Jiang D; Dong X; Deng S; Yang L; Guan Y; Zhu L; Zhou Y; Zhang X; Li H
    Exp Neurol; 2013 Sep; 247():506-16. PubMed ID: 23360804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases.
    Bordet R; Ouk T; Petrault O; Gelé P; Gautier S; Laprais M; Deplanque D; Duriez P; Staels B; Fruchart JC; Bastide M
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1341-6. PubMed ID: 17073815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms.
    Bhateja DK; Dhull DK; Gill A; Sidhu A; Sharma S; Reddy BV; Padi SS
    Eur J Pharmacol; 2012 Jan; 674(1):33-43. PubMed ID: 22056833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
    Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I
    J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.